Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | EXP | Common Stock | 16K | Aug 5, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | EXP | Non-Qualified Stock Option (Right to Buy) | Aug 5, 2022 | Common Stock | 791 | $106.24 | Direct | F2 | ||||||
holding | EXP | Non-Qualified Stock Option (Right to Buy) | Aug 5, 2022 | Common Stock | 735 | $106.24 | Direct | F3 | ||||||
holding | EXP | Non-Qualified Stock Option (Right to Buy) | Aug 5, 2022 | Common Stock | 4.82K | $91.58 | Direct | F4 | ||||||
holding | EXP | Non-Qualified Stock Option (Right to Buy) | Aug 5, 2022 | Common Stock | 4.57K | $91.58 | Direct | F5 | ||||||
holding | EXP | Non-Qualified Stock Option (Right to Buy) | Aug 5, 2022 | Common Stock | 2.29K | $60.21 | Direct | F6 | ||||||
holding | EXP | Non-Qualified Stock Option (Right to Buy) | Aug 5, 2022 | Common Stock | 1.91K | $60.21 | Direct | F7 |
Id | Content |
---|---|
F1 | This number includes the following restricted shares: (a) 701 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse on 3/31/2023; (b) 3,083 shares remaining from a grant awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2023 and 2024; (c) 2,666 shares remaining from a grant awarded to the reporting person on 5/19/2021, the restrictions on which will lapse ratably on March 31 of 2023, 2024 and 2025; and (d) 1,783 shares awarded to the reporting person on 5/19/2022, the restrictions on which will lapse ratably on March 31 of 2023, 2024, 2025 and 2026. |
F2 | On May 17, 2018, the reporting person was granted an option to purchase up to 3,528 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 3,165 shares, 791 of which remain exercisable. |
F3 | On May 17, 2018 the reporting person was granted an option to purchase up to 2,940 shares of Common Stock, and currently 735 of these options remain exercisable. |
F4 | On May 16, 2019, the reporting person was granted an option to purchase up to 5,481 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 4,824 shares. Currently 3,618 options are exercisable and the remaining options vest on March 31, 2023. |
F5 | On May 16, 2019 the reporting person was granted an option to purchase up to 4,568 shares of Common Stock. Currently 3,426 options are exercisable and the remaining options will vest on March 31, 2023. |
F6 | On May 19, 2020, the reporting person was granted an option to purchase up to 3,057 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2021. On May 6, 2021, the performance conditions were determined to have been satisfied such that stock options vested as to 3,057 shares. Currently 764 options are exercisable and the remaining options vest on March 31 of 2023 and 2024. |
F7 | On May 19, 2020 the reporting person was granted an option to purchase up to 2,548 shares of Common Stock. Currently 637 options are exercisable and the remaining options will vest ratably on March 31 of 2023 and 2024. |